Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
RGS4 5999 PERPHENAZINE CHEMBL567 PharmGKB
RGS4 5999 OLANZAPINE CHEMBL715 PharmGKB
RGS4 5999 RISPERIDONE CHEMBL85 PharmGKB

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
RGS4 rs2661319 C risperidone efficacy yes Allele C is associated with decreased response to risperidone in people with Schizophrenia as compared to allele T. 18204343 613979204
RGS4 rs951436 C antipsychotics efficacy no Allele C is not associated with response to antipsychotics in people with Schizophrenia as compared to allele A. 16604300 655387115
RGS4 rs2842030 TT olanzapine efficacy not stated compared to quetiapine, risperidone or ziprasidone based on Positive and Negative Syndrome Scale (PANSS) positive scores Genotype TT is associated with increased response to olanzapine and perphenazine in people with Schizophrenia as compared to genotypes GG + GT. 17588543 608431246
RGS4 rs2842030 GG risperidone efficacy not stated compared to perphenazine, quetiapine, and ziprasidone treatment Genotype GG is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes GT + TT. 17588543 608431255
RGS4 rs951439 TT quetiapine efficacy not stated Genotype TT is associated with increased response to quetiapine and ziprasidone in people with Schizophrenia as compared to genotype CC. 17588543 655387138
RGS4 rs10917670 TT risperidone efficacy no did not significantly influence end-point scores of any scale after Bonferroni correction for multiple comparisons Genotype TT is associated with increased response to risperidone in people with Schizophrenia as compared to genotype CC. 18204343 655387136